356 related articles for article (PubMed ID: 16395264)
1. A pathogenic role for secretory IgA in IgA nephropathy.
Oortwijn BD; van der Boog PJ; Roos A; van der Geest RN; de Fijter JW; Daha MR; van Kooten C
Kidney Int; 2006 Apr; 69(7):1131-8. PubMed ID: 16395264
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of secretory IgA in kidneys of patients with IgA nephropathy.
Oortwijn BD; Rastaldi MP; Roos A; Mattinzoli D; Daha MR; van Kooten C
Nephrol Dial Transplant; 2007 Nov; 22(11):3191-5. PubMed ID: 17545679
[TBL] [Abstract][Full Text] [Related]
3. Application of Oxford classification, and overexpression of transforming growth factor-β1 and immunoglobulins in immunoglobulin A nephropathy: correlation with World Health Organization classification of immunoglobulin A nephropathy in a Chinese patient cohort.
Meng H; Zhang L; E X; Ye F; Li H; Han C; Yamakawa M; Jin X
Transl Res; 2014 Jan; 163(1):8-18. PubMed ID: 23891568
[TBL] [Abstract][Full Text] [Related]
4. The level of serum secretory IgA of patients with IgA nephropathy is elevated and associated with pathological phenotypes.
Zhang JJ; Xu LX; Liu G; Zhao MH; Wang HY
Nephrol Dial Transplant; 2008 Jan; 23(1):207-12. PubMed ID: 17938148
[TBL] [Abstract][Full Text] [Related]
5. Secretory immunoglobulin A (IgA) responses in IgA nephropathy patients after mucosal immunization, as part of a polymeric IgA response.
Eijgenraam JW; Oortwijn BD; Kamerling SW; de Fijter JW; van den Wall Bake AW; Daha MR; van Kooten C
Clin Exp Immunol; 2008 May; 152(2):227-32. PubMed ID: 18336594
[TBL] [Abstract][Full Text] [Related]
6. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
Wang Y; Zhao MH; Zhang YK; Li XM; Wang HY
Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
[TBL] [Abstract][Full Text] [Related]
7. Role of Human Mesangial-Tubular Crosstalk in Secretory IgA-Induced IgA Nephropathy.
Zhang J; Zhou R; Mi Y; Liu Z; Huang B; Guo R; Wang P; Quan S; Zhou Y
Kidney Blood Press Res; 2021; 46(3):286-297. PubMed ID: 33866316
[TBL] [Abstract][Full Text] [Related]
8. Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy.
Leung JC; Tang SC; Lam MF; Chan TM; Lai KN
Kidney Int; 2001 Jan; 59(1):277-85. PubMed ID: 11135081
[TBL] [Abstract][Full Text] [Related]
9. MiR-100-3p and miR-877-3p regulate overproduction of IL-8 and IL-1β in mesangial cells activated by secretory IgA from IgA nephropathy patients.
Liang Y; Zhao G; Tang L; Zhang J; Li T; Liu Z
Exp Cell Res; 2016 Oct; 347(2):312-21. PubMed ID: 27542871
[TBL] [Abstract][Full Text] [Related]
10. Role of macromolecular IgA in IgA nephropathy.
van der Boog PJ; van Kooten C; de Fijter JW; Daha MR
Kidney Int; 2005 Mar; 67(3):813-21. PubMed ID: 15698421
[TBL] [Abstract][Full Text] [Related]
11. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
Moura IC; Arcos-Fajardo M; Gdoura A; Leroy V; Sadaka C; Mahlaoui N; Lepelletier Y; Vrtovsnik F; Haddad E; Benhamou M; Monteiro RC
J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic IgA in IgA nephropathy: still the blind men and the elephant?
Lai KN
Kidney Int; 2006 Apr; 69(7):1102-3. PubMed ID: 16609676
[TBL] [Abstract][Full Text] [Related]
13. Proliferation and Cytokine Production of Human Mesangial Cells Stimulated by Secretory IgA Isolated from Patients with IgA Nephropathy.
Liang Y; Zhang J; Zhou Y; Xing G; Zhao G; Liu Z
Cell Physiol Biochem; 2015; 36(5):1793-1808. PubMed ID: 26184511
[TBL] [Abstract][Full Text] [Related]
14. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.
Novak J; Tomana M; Matousovic K; Brown R; Hall S; Novak L; Julian BA; Wyatt RJ; Mestecky J
Kidney Int; 2005 Feb; 67(2):504-13. PubMed ID: 15673298
[TBL] [Abstract][Full Text] [Related]
15. Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy.
Lai KN; To WY; Li PK; Leung JC
Kidney Int; 1996 Mar; 49(3):839-45. PubMed ID: 8648928
[TBL] [Abstract][Full Text] [Related]
16. Size-dependent binding of IgA to HepG2, U937, and human mesangial cells.
Leung JC; Tsang AW; Chan LY; Tang SC; Lam MF; Lai KN
J Lab Clin Med; 2002 Dec; 140(6):398-406. PubMed ID: 12486407
[TBL] [Abstract][Full Text] [Related]
17. Serum secretory IgA and IgM and free secretory component in IgA nephropathy.
Mole CM; Renoult E; Béné MC; Seillès E; Kessler M; Revillard JP; Faure GC
Nephron; 1995; 71(1):75-8. PubMed ID: 8538852
[TBL] [Abstract][Full Text] [Related]
18. Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy.
Valentijn RM; Radl J; Haaijman JJ; Vermeer BJ; Weening JJ; Kauffmann RH; Daha MR; van Es LA
Kidney Int; 1984 Nov; 26(5):760-6. PubMed ID: 6441067
[TBL] [Abstract][Full Text] [Related]
19. [Serum IgA-fibronectin complex in children with various renal diseases].
Sakai Y; Inaba S; Matsukura H; Okada T
Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1130-6. PubMed ID: 7815745
[TBL] [Abstract][Full Text] [Related]
20. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
